Insulin aspart, recombinant Subcutaneous and Polyethylene glycol 3350
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Polyethylene glycol 3350 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: polyethylene glycol 3350
Brand name: ClearLax, GaviLAX, Gialax, GlycoLax, MiraLAX, PEG3350, SunMark ClearLax, HealthyLax, GaviLAX, MiraLAX
Synonyms: Polyethylene Glycol 3350
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Polyethylene glycol 3350 and electrolytes
- Insulin aspart, recombinant Subcutaneous-Polyethylene glycol 3350, electrolytes, and ascorbic acid
- Insulin aspart, recombinant Subcutaneous-Polyethylene glycol 3350, sodium and potassium salts
- Insulin aspart, recombinant Subcutaneous-Polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride, and potassium chloride
- Insulin aspart, recombinant Subcutaneous-Polyethylene glycol electrolyte solution
- Insulin aspart, recombinant Subcutaneous-Polyethylene Glycol-Electrolyte Solution (MoviPrep, Plenvu)
- Polyethylene glycol 3350-Insulin degludec
- Polyethylene glycol 3350-Insulin Degludec (U-100) Prefilled Pens
- Polyethylene glycol 3350-Insulin Degludec (U-100) Vials
- Polyethylene glycol 3350-Insulin Degludec (U-200) Prefilled Pens
- Polyethylene glycol 3350-Insulin degludec and liraglutide
- Polyethylene glycol 3350-Insulin degludec and liraglutide Subcutaneous